
Vimta Labs Q1 Results FY27: Net Profit Rises 11.37% to Rs 21 Cr as Revenue Grows 11.8%
Vimta Labs Q1 FY27: PAT Rs 21 Cr (+11.37% YoY), revenue Rs 109 Cr (+11.8%). Stock fell 5.18% to Rs 530.25 on 20 July 2026.
Updated: 21 Jul 2026 • 10:05 am
Posted by:

Vimta Labs Q1 results FY27 are out. The company reported a standalone net profit of Rs 21 Cr for the quarter ended 30 June 2026, up 11.37% from Rs 18 Cr in the year ago quarter, in results announced on Monday, 20 July 2026.
Shares of Vimta Labs fell 5.18% to Rs 530.25 on the results day. The company is a contract research, testing and certification laboratory.
Click Here – Get Free Investment Predictions
Vimta Labs Q1 Results FY27 Key Takeaways
Here are the most important numbers from the June 2026 quarter at a glance.
- Net Profit (PAT): Rs 21 Cr in Q1 FY27 versus Rs 18 Cr in Q1 FY26, a change of +11.37% year on year.
- Revenue: Rs 109 Cr in Q1 FY27 versus Rs 97 Cr in Q1 FY26, a change of +11.8%.
- Gross Profit: Rs 24 Cr in Q1 FY27 versus Rs 23 Cr in Q1 FY26, a change of +3.92%.
- Results announced on Monday, 20 July 2026 for the quarter ended 30 June 2026 on a standalone basis.
- Vimta Labs share price fell 5.18% to Rs 530.25 on the results day.
Vimta Labs Q1 Results FY27 Financial Highlights
The table below summarises the standalone numbers reported in the Vimta Labs Q1 results FY27 against the year ago quarter.
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue | Rs 109 Cr | Rs 97 Cr | +11.8% |
| Gross Profit | Rs 24 Cr | Rs 23 Cr | +3.92% |
| Net Profit (PAT) | Rs 21 Cr | Rs 18 Cr | +11.37% |
All figures are on a standalone basis as reported for the quarter ended 30 June 2026.
Vimta Labs Q1 Results FY27 Performance Analysis
Get Personalised Guidance from a SEBI-Registered Investment Advisor
Profit growth is the headline of the Vimta Labs Q1 results FY27. Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. Gross profit rose 3.92% to Rs 24 Cr from Rs 23 Cr.
The broad based improvement across revenue, gross profit and net profit in the Vimta Labs Q1 results FY27 suggests the quarter's growth is operational rather than driven by one off items.
Vimta Labs Q1 Results FY27: Key Business Factors
1. Topline Momentum
Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. This sets the base against which the rest of the P&L in the Vimta Labs Q1 results FY27 should be read.
2. Operating Performance
Gross profit rose 3.92% to Rs 24 Cr from Rs 23 Cr. The gross profit trend is the cleanest read on operating health in the quarter.
3. Bottom Line Delivery
The net result of Rs 21 Cr captures the combined effect of operations, other income, finance costs and tax for the quarter.
Dividend Details
Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company's official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.
Vimta Labs Q1 Results FY27 Outlook for the Full Year
The Vimta Labs Q1 results FY27 set the tone for FY27. The next markers are the September quarter numbers, any guidance from management, and how costs and demand evolve through the festive half of the year.
Vimta Labs Stock Performance After the Q1 Results
Download the Univest iOS App or Univest Android App to track Vimta Labs live share price and upcoming quarterly results.
Vimta Labs share price fell 5.18% to Rs 530.25 on the results day, as the market weighed the quarter's numbers against expectations.
Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.
Key Risks
Investors going through the fine print of the Vimta Labs Q1 results FY27 should also weigh the following risks.
1. Sustaining the Growth Rate
The growth reported in the Vimta Labs Q1 results FY27 sets a higher base for coming quarters, and any moderation could disappoint a market that extrapolates.
2. Margin Durability
Whether the quarter's operating performance holds depends on input costs, pricing power and mix, all of which can shift quickly.
3. Execution and External Risks
Demand cycles, regulatory changes and sector specific shocks remain outside management control and can reset expectations.
Conclusion
Vimta Labs Q1 results FY27 show standalone net profit of Rs 21 Cr for the quarter ended 30 June 2026, up 11.37% from Rs 18 Cr in the year ago quarter. Revenue grew 11.8% to Rs 109 Cr from Rs 97 Cr. The September quarter will show whether this quarter's trend extends. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Vimta Labs Q1 Results FY27
When were the Vimta Labs Q1 results FY27 announced?
Ans. The Vimta Labs Q1 results FY27 were announced on Monday, 20 July 2026, for the quarter ended 30 June 2026, on a standalone basis.
What is the PAT in the Vimta Labs Q1 results FY27?
Ans. The standalone PAT in the Vimta Labs Q1 results FY27 stood at Rs 21 Cr, a change of +11.37% from Rs 18 Cr in Q1 FY26.
What was the revenue in the Vimta Labs Q1 results FY27?
Ans. The revenue in the Vimta Labs Q1 results FY27 stood at Rs 109 Cr, a change of +11.8% from Rs 97 Cr in Q1 FY26.
What was the gross profit in the Vimta Labs Q1 results FY27?
Ans. Gross profit for the June 2026 quarter stood at Rs 24 Cr, compared with Rs 23 Cr in Q1 FY26, a change of +3.92% year on year.
Are the Vimta Labs Q1 results FY27 standalone or consolidated?
Ans. The figures discussed here are on a standalone basis, as reported for the quarter ended 30 June 2026.
How did the share price react after the Vimta Labs Q1 results FY27?
Ans. Vimta Labs share price fell 5.18% to Rs 530.25 on the results day.
Is the stock a good buy after the Vimta Labs Q1 results FY27?
Ans. The Vimta Labs Q1 results FY27 are one input among many. Valuation, sector conditions and risk appetite matter as much as a single quarter. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.
Where can I verify the Vimta Labs Q1 results FY27?
Ans. The official filings for the Vimta Labs Q1 results FY27 are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.
Recent Articles

Eternal Share Price Hits a Record High at Rs 372: IPO Investors Sit on 375% Gains, but a Q2 Profit Miss, a 135x P/E and Blinkit Cash Burn Need a Closer Look
11 November 2026

Antala Industries IPO Listing: Shares Debut at 20% Discount on BSE SME, Check Share Price
11 November 2026

Bajaj Finance QIP of Up to Rs 11,700 Crore and Bajaj Finance Warrants at Rs 1,010: How the Rs 17,500 Crore Raise Works, a Dilution Estimate, What Is Not Yet Disclosed, and the Risks
11 November 2026

Why JPMorgan Picks PhysicsWallah, Meesho and Three Other Consumer Internet Stocks: Overweight Calls, Targets of Rs 148 and Rs 250, Q2 Results of Peers, and the Gaps I Could Not Fill
11 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Eternal Share Price Hits a Record High at Rs 372: IPO Investors Sit on 375% Gains, but a Q2 Profit Miss, a 135x P/E and Blinkit Cash Burn Need a Closer Look
Antala Industries IPO Listing: Shares Debut at 20% Discount on BSE SME, Check Share Price
Bajaj Finance QIP of Up to Rs 11,700 Crore and Bajaj Finance Warrants at Rs 1,010: How the Rs 17,500 Crore Raise Works, a Dilution Estimate, What Is Not Yet Disclosed, and the Risks
Why JPMorgan Picks PhysicsWallah, Meesho and Three Other Consumer Internet Stocks: Overweight Calls, Targets of Rs 148 and Rs 250, Q2 Results of Peers, and the Gaps I Could Not Fill
Should You Invest in OMC Stocks Such as HPCL, BPCL and IOCL? Brent Below $90, a Q2 Profit Rebound, a Rs 67,900 Crore LPG Burden, and the Inventory Loss Risk to Weigh First

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





